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Abstract
Background—Cancer programs are increasingly required to use survivorship care plans (SCPs). 
Compliance with SCP use requirements will be evaluated at the cancer program level. Cancer 
program-level determinants of SCP use may suggest strategies for compliance. The objective of 
this study was to describe SCP use and identify its cancer program-level determinants.
Methods—We surveyed employees knowledgeable about survivorship practices in cancer 
programs throughout the United States with a wide range of annual incident cancers, program 
types, and cancer care quality improvement organization memberships (81/100 response rate). We 
used descriptive statistics to describe SCP use and bivariate statistics to identify its cancer 
program-level determinants.
Results—Most respondents (56%) reported that SCPs were not used. In programs reporting use, 
SCP use is restricted primarily to breast (82%) and colorectal (55%) cancer survivors, and few 
providers use SCPs. When developed, SCPs seldom reach survivors and their primary care 
providers. Most respondents (78%) reported beginning to use SCPs because of requirements. 
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(29%), and lack of advocacy for SCP use from influential people (24%). SCP use was positively 
associated with academic program type (p=.009) and membership in the National Cancer 
Institute’s Community Cancer Centers Program (p=.009) and negatively associated with 
freestanding program type (p=.02).
Conclusion—SCP use in United States cancer programs is highly inconsistent. Many cancer 
programs plan to implement SCPs to comply with SCP use requirements. Support specifically 
intended to facilitate SCP use may be more effective than non-specific resources.
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Introduction
The transition from cancer treatment to follow-up care is often difficult for the nearly 14 
million cancer survivors in the United States [31]. Survivors have unique physical, 
psychological, social, and spiritual health needs that are optimally addressed through (1) the 
prevention and detection of new cancers, (2) surveillance for cancer spread or recurrence, 
(3) intervention for consequences of cancer and its treatment, and (4) coordination between 
oncologists and primary care providers (PCPs) [15]. Optimal care may be compromised by 
PCPs’ and oncologists’ conflicting perspectives on their roles in survivorship care; these 
conflicting perspectives may result in the duplication or omission of services [6]. Survivors 
often report feeling poorly educated regarding psychological, social, and sexual health issues 
[26] and their risk for recurrence [18], and they report being dissatisfied with care following 
cancer treatment [14].
To facilitate cancer survivors’ transition to follow-up care, beginning in 2015, cancer 
programs accredited by the Commission on Cancer (CoC) must demonstrate that they have 
developed and implemented a process for providing survivorship care plans (SCPs) – 
written documents that often, but not always, include a summary of cancer treatment and 
recommendations for surveillance, preventive care, wellness behaviors, and symptoms to 
report following treatment [15, 8]. Increasing numbers of cancer care quality improvement 
organizations (e.g., National Coalition for Cancer Survivorship [22]; American Society for 
Clinical Oncology [2]; National Comprehensive Cancer Network [24]; National Cancer 
Institute Community Cancer Centers Program [21]) have issued similar recommendations 
and guidelines.
CoC and other cancer care quality improvement organizations plan to evaluate compliance 
with SCP use requirements at the cancer program level (e.g., whether or not a process for 
providing SCPs has been developed and implemented in the cancer program). As such, 
understanding determinants of SCP use at the cancer program level may facilitate 
compliance with SCP use requirements. Most existing studies assess determinants of SCP 
use at the provider or patient level [13, 12, 11, 28]. The little evidence that exists regarding 
cancer program-level determinants of SCP use is tangential to primary research findings, 
from a single state [20], or from a very small number of cancer programs [32, 30, 5].
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A recently published study analyzes the 36 cancer programs of the 81 cancer programs 
analyzed in the present study that reported sometimes or regularly using SCPs [4]. The 
recently published study answered the question, “Among cancer programs reporting at least 
some SCP use, how consistently are SCPs used (i.e., developed and delivered to all 
survivors and their PCPs)?” A key implication of the recently published study’s results was 
that cancer care quality improvement organizations (e.g., Commission on Cancer) should 
clearly specify how compliance with survivorship care plan use requirements will be 
assessed. In contrast, the objective of the present study was to answer the question, “What 
are cancer program-level determinants of whether or not survivorship care plans are used in 
US cancer programs?” In fulfilling this objective, the present study fills a gap in the 
literature and suggests strategies for promoting SCP use that will be useful to the 
practitioners who will be held accountable for ensuring that their cancer programs comply 
with SCP use requirements.
Methods
Study sample
We conducted a cross-sectional survey of cancer programs throughout the US with a wide 
range of annual incident cancers, program types, and cancer care quality improvement 
organization memberships. A sampling frame was created for programs with membership in 
at least one of the following cancer care quality improvement organizations: CoC [9], the 
Association of Community Cancer Centers [3], the National Comprehensive Cancer 
Network [23], and/or the American Society of Clinical Oncology’s Quality Oncology 
Practice Initiative [1]. We took this approach because CoC programs serve 80 percent of all 
newly diagnosed US cancer patients [9]; therefore, our sampling frame included programs 
that serve the majority of US cancer survivors. We improved upon these figures by 
including programs that were members of cancer care quality improvement organizations 
other than CoC.
After eliminating programs in the same state with the same name, 1,991 programs were 
included in the sampling frame. We eliminated another 141 programs that were duplicate 
listings of programs with different names but the same location and/or staff. The final 
sampling frame included a total of 1,850 programs. The primary objective of our study was 
to estimate SCP use in US cancer programs with 95% confidence intervals that were no 
wider than ±10%. The standard error of an estimator depends on sample size; we determined 
that a sample size of 100 was sufficient to achieve our objective: If 50% of cancer programs 
were to use SCPs, the half-width of the 95% confidence interval would be ±10.2%; smaller 
or larger estimates would result in an even smaller half-width of the 95% confidence 
interval. In addition, a sample of 100 cancer programs was sufficient to assess exploratory 
associations with hypothesized determinants, and a sample of 100 cancer programs was 
manageable given the time-consuming process of identifying potential survey respondents 
(see method described below).
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The survey was based on a review of the Institute of Medicine’s report: From Cancer Patient 
to Cancer Survivor: Lost in Transition [15] and scientific literature. A team of experts 
developed the survey. Survivorship experts, including a practicing provider of breast cancer 
survivorship care, ensured that the survey reflected relevant clinical and policy issues, such 
as the importance of developing and delivering SCPs to survivors and their PCPs, and 
activities of key cancer care quality improvement organizations. Experts in dissemination 
and implementation of innovations in cancer care ensured that the survey reflected key 
dimensions of the innovation life cycle, such as dissemination, diffusion, adoption, and 
implementation. Survey methodologists promoted the likelihood that potential respondents 
would complete the survey. We also refined the survey based on cognitive interviews with 8 
employees who had knowledge of survivorship practices in programs not included in the 
final study sample. Survey items were phrased to elicit responses regarding SCP use any 
time in their program’s history. The final survey consisted of 15 items (see Table 1).
Survey respondent identification
We acknowledge that SCP use may vary within cancer programs. However, given our 
objective of identifying organization-level determinants of SCP use consistency, we sought 
a single respondent per program who could answer questions about their program’s 
characteristics (e.g., annual incident cancers). The following method was used to identify 
potential respondents. A research assistant used publicly available information to call 
sampled programs to identify employees with knowledge regarding survivorship practices 
who could respond to the survey. The research assistant asked for someone in the program 
who knew about how the program’s survivors were transitioned to follow-up care after 
treatment was complete. This process continued until the research assistant identified an 
employee in the program who would be able to answer questions regarding (1) whether or 
not SCPs were used in the program and (2) reasons why SCPs were or were not used in the 
program. The research assistant collected a specific address, direct phone number, and email 
address for the employee.
Survey administration
The survey was conducted between January and May 2013 using the standards of Dillman’s 
Total Design Method [10]. Initially, depending on the availability of an email address, we 
sent an email or a letter to respondents letting them know that they would receive an 
invitation to complete the survey in a few days. Three days later, we sent an introductory 
email with a link to an online version of the survey or an envelope containing a cover letter, 
survey, and return envelope. Emails or postcards were sent to thank respondents who 
completed the survey and to remind non-respondents to complete the survey. Two weeks 
after the initial survey mailing, replacement surveys were sent to non-respondents by first 
class mail or email. Two weeks later, non-respondents were called to request a response. 
This pattern repeated, allowing two-week intervals between contacts for as many as ten total 
attempts. Upon completing the survey, respondents had the option of being entered into a 
raffle to win an iPad. An employee with knowledge of survivorship practices from 81 of the 
100 programs contacted completed the survey (81% response rate). The institutional review 
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board at the University of North Carolina at Chapel Hill exempted the study from human 
subjects review.
Variable descriptions
SCP use—Survey items and response options are listed in Table 1. The survey included 
the following definition of an SCP: “a written document that often, but not always, includes 
the following information regarding care after cancer treatment is complete: treatment 
summary; surveillance plan; preventive care; and symptoms to report.”
We based our measure of SCP use on the Institute of Medicine’s report [15], the third 
author’s clinical experience, and feedback from cognitive interview participants. Our 
primary measure of SCP use was whether or not SCPs were used at the time of the survey. 
We categorized programs as using SCPs if respondents reported using SCPs “regularly” or 
“sometimes.” We categorized programs as not using SCPs if respondents reported no longer 
using, not currently using but planning to use, or not currently using and not planning to use 
SCPs. Secondary measures were used to understand the breadth and depth of SCP use within 
programs. We operationalized breadth of SCP use – i.e., how widespread SCP use was in the 
program – as the percentage of providers who used SCPs and the percentage of survivors for 
whom SCPs were used. We conceptualized depth of SCP use as the extent to which cancer 
programs’ SCP use went beyond developing SCPs to delivering SCPs to their intended 
audience: survivors and their PCPs; we operationalized depth of SCP use as the percentage 
of survivors whom SCPs were delivered and the percentage of PCPs to whom SCPs were 
delivered. To further characterize SCP use, we asked respondents when SCP use began and 
in which tumor groups SCPs were used.
Determinants of SCP use—Based on the notion that innovations are used when the 
motivation, means, and opportunity exists [33], we organized determinants of SCP use at the 
cancer program level in three categories: To understand the motivation to use SCPs, we 
asked respondents why SCPs were used in their programs (i.e., reasons for SCP use). To 
assess whether or not cancer programs had the means to use SCPs, we asked respondents 
about barriers to SCP use in their program. We operationalized the opportunity to use SCPs 
as cancer program characteristics that might influence the likelihood that cancer programs 
would use SCPs. Studies have shown relationships between health services utilization and 
geographic location. To assess geographic variation in SCP use, we captured programs’ 
location using ZIP codes. When available, ZIP codes were converted to rural/urban 
indicators using Rural-Urban Commuting Areas data [27]. ZIP codes were identified as a 
rural or urban subtype; subtypes were aggregated into dichotomous rural and urban 
categories. To assess whether SCP use was more likely to be reported in larger programs 
due to, for example, better infrastructure, we operationalized annual incident cancers as a 
program’s unduplicated number of cancer patients. American College of Surgeons assigns 
the program types listed in Table 1 based on organization type (e.g., academic), services 
provided, and number of cancer patients served [1]. We assessed differences in SCP use 
across program types because, for example, National Cancer Institute-designated 
comprehensive cancer programs engage in research that may assist programs in using SCPs. 
To assess variation in SCP use associated with cancer care quality improvement 
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organizations’ SCP use guidelines and recommendations, we asked respondents whether 
their program was a member of one of the organizations listed in Table 1. Since program 
members’ professional background may influence their perspective on SCP use, respondents 
were also asked which position they held at their program at the time of the survey.
Analysis
To describe SCP use and hypothesized determinants, we report response frequencies and 
percentages. To compare (1) respondents to programs in the sampling frame not randomly 
selected for inclusion in the study sample and (2) programs that used SCPs to those that did 
not use SCPs, we used Wilcoxon Rank Sum tests for continuous independent variables (e.g., 
annual incident cancers) and Fisher’s exact tests for categorical independent variables (e.g., 
program type). Unadjusted two-tailed p-values are reported. Relationships between variables 
were considered significant at the p<.05 level. The unit of analysis was the program. 
Analyses were conducted using SAS statistical software v9.3 (Cary, NC).
Results
Descriptive statistics are reported in Table 1. There were no differences in location, annual 
incident cancers, or program type between programs that returned surveys and programs that 
were not included in the sample (all p>0.13).
SCP use
Forty-four percent of respondents reported that SCPs were used in their programs at the time 
of the survey: Thirty percent reported that SCPs were used sometimes, and 15 percent 
reported that SCPs were used regularly. Of respondents who reported that their programs did 
not use SCPs at the time of the survey (56%), most indicated that they planned to use SCPs 
(93%).
In 58 percent of programs reporting SCP use at the time of the survey, less than a quarter of 
providers had ever used SCPs. The majority of respondents (69%) indicated that SCPs were 
used for fewer than half of survivors in their programs. Most respondents reported that SCPs 
were delivered to half or fewer of survivors for whom SCPs were developed (63%) or their 
PCPs (61%). Current or planned SCP use was restricted primarily to breast (82%) and 
colorectal (56%) cancer survivors.
Determinants of SCP use
Barriers to SCP use—The most commonly reported barrier to SCP use was lack of 
resources (76%). Other commonly cited barriers included the perception that SCPs are 
difficult to use (29%) and that influential people (e.g., physician champions, managers) had 
not advocated for SCPs to be used (24%).
Reasons for SCP use—The most commonly cited reason for SCP use was CoC’s 2012 
program standards (78%). Indeed, in the majority of programs (57%), SCP use began in 
2012 or 2013, after CoC issued program standards related to SCP use. Other commonly 
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cited reasons for SCP use were the belief that SCPs may improve quality of care (75%) and 
National Comprehensive Cancer Network guidelines (54%).
Cancer Program Characteristics—Of the 77 respondents who reported their position, 
most were registered nurses (39%), nurse practitioners (19.5%), or other clinical staff 
(19.5%). Respondents reported an average of 1,280 annual incident cancers (range 1–
14,000) in their programs. A third of respondents were employed in community 
comprehensive cancer programs (33%), a quarter were employed in community hospital 
cancer programs (24%), 12 percent came from academic cancer programs, and less than 10 
percent of sampled programs fell into other program type categories. Most respondents’ 
programs were members of CoC (77%), and more than a third were members of the 
American Society of Clinical Oncology’s Quality Oncology Practice Initiative (37%) and 
National Comprehensive Cancer Network (36%).
Relationships between SCP use and hypothesized determinants
Neither barriers nor reasons for SCP use were statistically significantly associated with SCP 
use.
Academic programs (89% v 38%, p=.009) and those with NCCCP membership (89% v 
38%, p=.009) were significantly more likely to indicate current SCP use. Freestanding 
programs were significantly less likely to report current SCP use (0% v 48%, p=.02). Other 
relationships were not statistically significant.
Discussion
The objective of this study was to describe SCP use and identify its cancer program-level 
determinants in cancer programs throughout the US with a wide range of annual incident 
cancers, program types, and cancer care quality improvement organization memberships. 
Results indicate that, in the majority of US cancer programs, SCPs are not used. This is 
consistent with other estimates of SCP use in US cancer programs, which range from 14 to 
53 percent [20, 7, 5, 30].
Also consistent with previous studies, we found that when SCPs are developed, they are 
infrequently delivered to survivors or PCPs [20, 17, 28]. Addressing the gap we found 
between SCP development and delivery to survivors and their PCPs is important given 
evidence of disparities in the receipt of SCPs across survivor age and gender [16]. There are 
several possible explanations for the gap that we found between SCP development and 
delivery to survivors and their PCPs: Cancer programs may not have fully implemented 
SCPs at the time of the survey – nearly two years before SCP use requirements take effect; 
programs may lack the resources to deliver SCPs; or they may develop SCPs to meet 
minimum standards for compliance with cancer care quality improvement organizations’ 
SCP use requirements.
Nevertheless, we found no associations between SCP use and cancer care quality 
improvement organizations’ requirements or guidelines. Instead, we found that membership 
in the NCCCP was positively associated with SCP use. NCCCP offers member programs 
Birken et al. Page 7






















support that is specifically intended to promote SCP use (e.g., SCP templates for breast 
cancer survivors) [25]. Similarly, we found that academic programs were more likely to use 
SCP. Academic cancer programs provide postgraduate medical education and participate in 
cancer-related clinical trials, which may give academic cancer programs access to cutting-
edge knowledge regarding best survivorship practices. Taken together, our results suggest 
that support specifically intended to facilitate SCP use may promote SCP use more 
effectively than the non-specific resources (e.g., time, staff, training, money) that are 
commonly cited as determinants of SCP use [20, 7, 11, 5, 13, 19, 29].
Limitations
Our study has several limitations. Survey items were not validated. In addition, we did not 
assess the reliability of our survey items; only one employee in each cancer program 
responded to the survey. It is unclear whether another employee would have responded 
similarly. Social desirability bias may have caused respondents to over-report SCP use. 
Future research should assess the reliability and validity of survey items intended to measure 
SCP use at the cancer program level.
Our sampling frame only included cancer care programs that were members of the cancer 
care quality improvement organizations listed in Table 1; it excluded programs that were not 
members of any of these cancer care quality improvement organizations. Members may be 
more likely to use SCPs, so our estimates of SCP use may understate SCP use in US cancer 
programs. In addition, the final sampling frame may have retained duplicates, despite our 
efforts to eliminate them. These issues emphasize the need for a comprehensive list of 
programs that provide cancer treatment as a resource for researchers who study cancer 
programs.
Our sample size limited our ability to detect small but potentially meaningful differences 
regarding relationships between SCP use and hypothesized determinants. Further, 
respondents who agreed to participate in the study may have been more likely to respond if 
their programs used SCPs; however, the variation in study outcomes suggests otherwise. 
Finally, we did not distinguish between sporadic use and consistent, proficient SCP use (i.e., 
effective implementation). Additional research is needed to better understand what 
distinguishes sporadic use from consistent, proficient SCP use.
Implications
Despite the limitations described above, our findings have implications for cancer care 
quality improvement organizations that require SCP use, cancer programs that seek 
compliance with these requirements, and the practitioners who will be held accountable for 
their programs’ compliance with SCP use requirements. Cancer care quality improvement 
organizations should take into consideration that cancer programs with particular 
characteristics may struggle to comply with SCP use requirements. In particular, we found 
that freestanding cancer program type was negatively associated with SCP use. Our results 
also suggest that, more generally, cancer programs that do not get support specifically 
intended to facilitate SCP use may struggle to comply with requirements. Cancer care 
quality improvement organizations may be a resource for this support.
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Cancer programs seeking to comply with SCP use requirements may benefit from support 
that is specifically intended to facilitate SCP use. Non-specific resources (e.g., time, staff, 
training, money) may be less effective in promoting SCP use. The practitioners who will be 
held accountable for their programs’ compliance with SCP use requirements may assist by 
identifying the specific support needed for SCP use.
Future research
Future research should examine differences in SCP use among members of cancer care 
quality improvement organizations and program types in subgroup analyses. Such analyses 
will require more cancer programs in each subgroup than were necessary for our exploratory 
analyses. Subgroup analysis would allow for future studies to identify mechanisms 
underlying relationships between program type and SCP use (e.g., What promotes SCP use 
in academic programs and deters it in freestanding programs?) and between NCCCP 
membership and SCP use (e.g., Does the support that NCCCP offers facilitate SCP use?). 
Understanding the mechanisms underlying these relationships may help to improve practice.
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